Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2018

The following table presents net revenues disaggregated by type:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Prescribed dietary supplements	$	2,096,851	$	—	$	5,766,642	$	—
Prescription drugs	1,977,935		—		7,279,182		—
Sales force revenue	—		—		296,875		—
License and other revenue	—		25,000,000		—		25,000,000
Grant revenue	—		37,592		—		579,597
Total revenue	$	4,074,786	$25,037,592		$	13,342,699	$25,579,597